Our study suggests that SIRT1 overexpression is an independent prognosticator for patients with ESCC and the SIRT1 inhibitor suppressed cell proliferation of ESCC cell lines. The gene discussed is SIRT1; the disease is esophageal squamous cell carcinoma.